H.C. Wainwright raised the firm’s price target on Sensus Healthcare (SRTS) to $11 from $10 and keeps a Buy rating on the shares. The company reported a top- and bottom-line beat in Q3 amid strong momentum in the Fair Deal agreement, As previously reported,
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks